These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 8411113

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
    Martinon F, Brochard P, Ripaux M, Delache B, Aurégan G, Vaslin B, Le Grand R.
    Vaccine; 2008 Jan 24; 26(4):532-45. PubMed ID: 18093703
    [Abstract] [Full Text] [Related]

  • 3. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.
    Stahl-Hennig C, Coulibaly C, Petry H, Voss G, Dittmer U, Bodemer W, Makoschey B, Jurkiewicz E, Lüke W, Hunsmann G.
    AIDS Res Hum Retroviruses; 1994 Jan 24; 10 Suppl 2():S27-32. PubMed ID: 7865316
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of protective efficacy of recombinant subunit vaccines against simian immunodeficiency virus infection of macaques.
    Hu SL, Abrams K, Misher L, Stallard V, Moran P, Zarling JM, Langlois AJ, Kuller L, Morton WR, Benveniste RE.
    J Med Primatol; 1992 Jan 24; 21(2-3):119-25. PubMed ID: 1433262
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.
    Hu SL, Abrams K, Barber GN, Moran P, Zarling JM, Langlois AJ, Kuller L, Morton WR, Benveniste RE.
    Science; 1992 Jan 24; 255(5043):456-9. PubMed ID: 1531159
    [Abstract] [Full Text] [Related]

  • 11. The appearance of escape variants in vivo does not account for the failure of recombinant envelope vaccines to protect against simian immunodeficiency virus.
    Almond N, Jenkins A, Jones S, Arnold C, Silvera P, Kent K, Mills KHG, Stott EJ.
    J Gen Virol; 1999 Sep 24; 80 ( Pt 9)():2375-2382. PubMed ID: 10501490
    [Abstract] [Full Text] [Related]

  • 12. Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone, but not with BK28-derived recombinant env and gag proteins.
    Mills KH, Page M, Chan WL, Kitchin P, Stott EJ, Taffs F, Jones W, Rose J, Ling C, Silvera P.
    J Med Primatol; 1992 Sep 24; 21(2-3):50-8. PubMed ID: 1433267
    [Abstract] [Full Text] [Related]

  • 13. Immune responses to SIVmne envelope glycoproteins protect macaques from homologous SIV infection.
    Hu SL, Travis BM, Stallard V, Abrams K, Misher L, Moran P, Zarling JM, Langlois AJ, Kuller L, Morton WR.
    AIDS Res Hum Retroviruses; 1992 Aug 24; 8(8):1489-94. PubMed ID: 1466988
    [No Abstract] [Full Text] [Related]

  • 14. Immunization of Macaca fascicularis with inactivated SIV preparations: challenge with human- or monkey-derived SIV and the effects of a longer immunization schedule.
    Titti F, Koanga Mogtomo ML, Borsetti A, Geraci A, Sernicola L, Panzini G, Turillazzi GP, Baroncelli S, Giovannetti A, Zamarchi R.
    J Med Primatol; 1993 Aug 24; 22(2-3):110-8. PubMed ID: 8411103
    [Abstract] [Full Text] [Related]

  • 15. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
    McKenna PM, Koser ML, Carlson KR, Montefiori DC, Letvin NL, Papaneri AB, Pomerantz RJ, Dietzschold B, Silvera P, McGettigan JP, Schnell MJ.
    J Infect Dis; 2007 Apr 01; 195(7):980-8. PubMed ID: 17330788
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X, Casimiro DR, Schleif WA, Wang F, Davies ME, Zhang ZQ, Fu TM, Finnefrock AC, Handt L, Citron MP, Heidecker G, Tang A, Chen M, Wilson KA, Gabryelski L, McElhaugh M, Carella A, Moyer C, Huang L, Vitelli S, Patel D, Lin J, Emini EA, Shiver JW.
    J Virol; 2005 Oct 01; 79(19):12321-31. PubMed ID: 16160159
    [Abstract] [Full Text] [Related]

  • 18. T-cell-mediated protective efficacy of a systemic vaccine approach in cynomolgus monkeys after SIV mucosal challenge.
    Michelini Z, Negri DR, Baroncelli S, Catone S, Comini A, Maggiorella MT, Sernicola L, Crostarosa F, Belli R, Mancini MG, Farcomeni S, Fagrouch Z, Ciccozzi M, Rovetto C, Liljestrom P, Norley S, Heeney J, Titti F.
    J Med Primatol; 2004 Oct 01; 33(5-6):251-61. PubMed ID: 15525326
    [Abstract] [Full Text] [Related]

  • 19. Persistence of low levels of simian immunodeficiency virus in macaques that were transiently viremic by conventional testing.
    Zhu T, Hu SL, Feng F, Polacino P, Liu H, Hwangbo Y, Learn GH, Mullins JI, Corey L.
    Virology; 2004 Jun 01; 323(2):208-19. PubMed ID: 15193917
    [Abstract] [Full Text] [Related]

  • 20. Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Guérin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity.
    Ami Y, Izumi Y, Matsuo K, Someya K, Kanekiyo M, Horibata S, Yoshino N, Sakai K, Shinohara K, Matsumoto S, Yamada T, Yamazaki S, Yamamoto N, Honda M.
    J Virol; 2005 Oct 01; 79(20):12871-9. PubMed ID: 16188989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.